arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

agilon health, inc.

AGL
$113.94 ▲ +17.76 (+18.47%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
26 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

agilon health, inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.9B
Dividend Yield —
Revenue Growth 7.2% ↗
Op. Margin 0.8% ↗
ROIC 78.2% ↗
FCF / Share $-3.64 ↘
Trailing P/E 106.5x
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.49B
↑ +7.2% —
Net Income Profit after all expenses
$17.96M
↓ -63.3% —
Operating Margin Operating profit as % of sales
0.8%
↑ +179.8% 17th
FCF / Share Free cash flow per share
$-3.64
↓ -392.6% —
Long-Term Debt Long-term obligations
$15.38M
↑ +0.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
19
Financial Health ↓
14
Cash Quality ↓
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 26 quarters